Loading…
agilon health, inc. is projected to rise to $155.61 by 2027, a +70% move from its current price of $91.61. AGL is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $87.17 | $91.69 | $96.45 | +0.09% |
| Aug 3 | $85.44 | $91.78 | $98.59 | +0.18% |
| Aug 4 | $84.15 | $91.86 | $100.28 | +0.27% |
| Aug 5 | $83.09 | $91.94 | $101.74 | +0.37% |
| Aug 6 | $82.18 | $92.03 | $103.05 | +0.46% |
| Aug 7 | $81.37 | $92.11 | $104.27 | +0.55% |
| Aug 8 | $80.64 | $92.20 | $105.40 | +0.64% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $80.64 | $92.20 | $105.40 | +0.64% |
| Week 2 | $76.78 | $92.79 | $112.13 | +1.28% |
| Week 3 | $74.05 | $93.38 | $117.75 | +1.93% |
| Week 4 | $71.90 | $93.98 | $122.83 | +2.59% |
| Week 5 | $70.11 | $94.58 | $127.59 | +3.24% |
| Week 6 | $68.57 | $95.19 | $132.13 | +3.90% |
| Week 7 | $67.22 | $95.80 | $136.52 | +4.57% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
agilon health, inc. (AGL) is a healthcare company that provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month.
The company was founded in 2016 and is based in Westerville, Ohio. It was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021.
AGL is a healthcare stock currently trading at $92.66 with a market capitalization of $1.55B. It is ranked 2225.
The near-term technical backdrop shows a bullish tilt, supported by RSI(14) at 40 and moving averages of $104.81 (SMA50) and $41.75 (SMA200). The built-in support and resistance levels sit at $92.66 and $129.84 respectively, with a 30-day range from $65.88 to $130.33.
The long-range outlook is positive, with year-by-year forecasts showing rising averages from $92.66 in 2026 to $211.24 by 2030, then to $613.16 in 2040 and $1,488.42 in 2050, along with substantial upside potential capped by a max forecast of $3,423.37 in 2050. The outlook includes bullish sentiment across most years and notable ROI growth through 2050.
A major floor 91.4% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 41.7% above — a clean break opens room to run.
A major ceiling 55.6% above — clearing it would confirm fresh momentum.
Key AGL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AGL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $95.72 | Sell | $96.44 | Sell |
| MA 10 | $104.46 | Sell | $101.86 | Sell |
| MA 20 | $110.79 | Sell | $106.16 | Sell |
| MA 50 | $105.07 | Sell | $97.94 | Sell |
| MA 100 | $66.95 | Buy | $78.18 | Buy |
| MA 200 | $42.47 | Buy | $61.75 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 38.29 | Neutral |
| Stoch RSI (14) | 2.10 | Buy |
| CCI (20) | -121.57 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -3.92 | Sell |
| ROC (12) | -26.29 | Sell |
| Bollinger %B (20,2) | 0.09 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.16 | Buy |
| Awesome (5,34) | -15.40 | Sell |
| Ultimate (7,14,28) | 23.38 | Buy |
| Momentum (10) | -38.23 | Sell |
| Aroon Osc (25) | -40.00 | Sell |
| Hull MA (9) | 90.86 | Buy |
| ADX (14) | 24.79 | Sell |
| ATR (14) | 4.71 | Info |
Sentiment is bullish overall for the near term. RSI(14) is 40, indicating modest momentum.
SMA50 is $104.81, while SMA200 is $41.75, placing the near-term price action above the short-term moving average alignment. Support sits at $92.66 and resistance at $129.84, framing a trading range that captures the stock’s volatility.
The 30-day trading range spans from a low of $65.88 to a high of $130.33, illustrating the recent price volatility and potential for further upside on positive catalysts.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $7.91 | $91.61 | $142.38 | 0% | Neutral | |
| $114.48 | $155.61 | $228.29 | +70% | Bullish | |
| $129.03 | $185.79 | $290.05 | +103% | Bullish | |
| $123.74 | $187.10 | $306.24 | +104% | Bullish | |
| $133.96 | $211.68 | $360.29 | +131% | Bullish | |
| $134.34 | $221.18 | $389.33 | +141% | Bullish | |
| $142.33 | $243.66 | $441.86 | +166% | Bullish | |
| $190.53 | $338.61 | $630.63 | +270% | Bullish | |
| $212.02 | $390.72 | $745.59 | +327% | Bullish | |
| $243.43 | $464.78 | $906.97 | +407% | Bullish | |
| $280.11 | $622.46 | $1,331.63 | +579% | Bullish | |
| $678.11 | $1,506.91 | $3,465.89 | +15.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $7.91 | $91.61 | $115.14 | +0.00% |
| September 2026 | $82.10 | $99.63 | $126.04 | +8.75% |
| October 2026 | $80.99 | $99.56 | $128.35 | -0.07% |
| November 2026 | $79.12 | $98.30 | $128.66 | -1.26% |
| December 2026 | $85.53 | $107.31 | $142.38 | +9.17% |
Click any year to see its month-by-month AGL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect AGL to range from $7.91 to $142.38 through 2026. The $91.61 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The AGL price prediction for 2027 points to an average of $155.61 (low $114.48, high $228.29) — a potential gain of +70% on today's $91.61. Momentum favours further upside here.
In 2028, AGL is projected to trade between $129.03 and $290.05, averaging $185.79 — a potential gain of +103% from today's $91.61. That is up +19% on the projected 2027 average. Buyers look set to stay in control over this stretch.
agilon health, inc.'s 2029 outlook centres on $187.10, within a $123.74 to $306.24 range. That is up +1% on the projected 2028 average. That marks a +104% change versus current levels. Momentum favours further upside here.
By 2030, AGL could reach as high as $360.29, with a base case around $211.68 and support toward $133.96 — roughly +131% from $91.61. Buyers look set to stay in control over this stretch.
Expect AGL to range from $134.34 to $389.33 through 2031. The $221.18 average target implies a +141% move from current prices. That is up +4% on the projected 2030 average. Momentum favours further upside here.
The AGL price prediction for 2032 points to an average of $243.66 (low $142.33, high $441.86) — a potential gain of +166% on today's $91.61. Buyers look set to stay in control over this stretch.
In 2033, AGL is projected to trade between $190.53 and $630.63, averaging $338.61 — a potential gain of +270% from today's $91.61. That is up +39% on the projected 2032 average. Momentum favours further upside here.
agilon health, inc.'s 2034 outlook centres on $390.72, within a $212.02 to $745.59 range. That is up +15% on the projected 2033 average. That marks a +327% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, AGL could reach as high as $906.97, with a base case around $464.78 and support toward $243.43 — roughly +407% from $91.61. Momentum favours further upside here.
Expect AGL to range from $280.11 to $1,331.63 through 2040. The $622.46 average target implies a +579% move from current prices. That is up +34% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The AGL price prediction for 2050 points to an average of $1,506.91 (low $678.11, high $3,465.89) — a potential gain of +15.4x on today's $91.61. Momentum favours further upside here.
Investing $1,000 in AGL today (≈ 10.915839 AGL) could be worth
$16,449.19
+$15,449.19 (+1545%) by 2050 · US Dollar
Based on the average projected AGL price of $1,506.91 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AGLwould be worth at today's price.
$1,000 invested in AGL on Jul 31, 2025 (≈ 22.346369 AGL) would be worth
$2,047.15
+$1,047.15 (+104.7%) today · 2.05× · US Dollar
Based on a AGL entry price of $44.75 vs. today's $91.61.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $98 | $934.8 | -6.5% |
| 1 month ago | $111.74 | $819.85 | -18.0% |
| 3 months ago | $29.58 | $3,097.03 | +209.7% |
| 6 months ago | $20.7 | $4,425.6 | +342.6% |
| 1 year ago | $44.75 | $2,047.15 | +104.7% |
| All time (5.0y) ago | $932 | $98.29 | -90.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AGL forecast.
Our base-case forecast reaches $180.00 around 2028.
Implied market cap at $180.00: $3B
The multi-year forecast shows strong upside, led by a 2030 avg of $211.24 with a 128% ROI and a bullish sentiment, followed by a 2040 avg of $613.16 with a 561.7% ROI and bullish sentiment, and a 2050 avg of $1,488.42 with a 1506.3% ROI and bullish sentiment.
Key intermediate years show continued upside: 2027 avg $157.48 (ROI 70, bullish), 2028 avg $187.43 (ROI 102.3, bullish), 2029 avg $188.44 (ROI 103.4, bullish), 2031 avg $220.58 (ROI 138.1, bullish), 2032 avg $243.05 (ROI 162.3, bullish), 2033 avg $336.47 (ROI 263.1, bullish), 2034 avg $389.38 (ROI 320.2, bullish), 2035 avg $464.19 (ROI 401, bullish).
The forecast also includes higher-end scenarios: 2033 max $632.09, 2034 max $749.72, 2035 max $914.24, and by 2040 max $1,325.41, culminating in 2050 max $3,423.37. While these projections show substantial potential, they are estimates and not guarantees, subject to market dynamics and other risks.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $211.24 with a min of $132.52 and a max of $362.20; ROI is 128% and sentiment is BULLISH.
The forecast indicates bullish sentiment from 2027 onward with upside potential, including 2027 avg $157.48 (ROI 70%) and 2050 avg $1,488.42 (ROI 1506.3%), max $3,423.37. These are estimates, not guarantees.
Yes. The 2050 forecast shows an avg of $1,488.42 and a max of $3,423.37, indicating the possibility of exceeding $1,000; the 2040 avg is $613.16, illustrating a long-run growth trajectory.
Low $65.88, High $130.33.
agilon health, inc. Community Discussion
0Share your agilon health, inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.